Tenaya Therapeutics, Inc.
TNYA
$0.4912
$0.03066.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -11.91% | -4.65% | 0.62% | 4.79% | 6.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.62% | -8.60% | -5.74% | 2.37% | 4.44% |
| Operating Income | 11.62% | 8.60% | 5.74% | -2.37% | -4.44% |
| Income Before Tax | 10.44% | 8.18% | 6.56% | -0.18% | -0.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 10.44% | 8.18% | 6.56% | -0.18% | -0.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.44% | 8.18% | 6.56% | -0.18% | -0.34% |
| EBIT | 11.62% | 8.60% | 5.74% | -2.37% | -4.44% |
| EBITDA | 12.27% | 9.14% | 6.21% | -1.63% | -2.81% |
| EPS Basic | 22.00% | 23.59% | 31.15% | 33.23% | 39.55% |
| Normalized Basic EPS | 22.02% | 23.60% | 31.16% | 33.24% | 39.55% |
| EPS Diluted | 21.85% | 23.45% | 31.15% | 33.30% | 39.61% |
| Normalized Diluted EPS | 22.02% | 23.60% | 31.16% | 33.24% | 39.55% |
| Average Basic Shares Outstanding | 15.19% | 18.60% | 29.45% | 43.31% | 64.37% |
| Average Diluted Shares Outstanding | 15.19% | 18.60% | 29.45% | 43.31% | 64.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |